Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Epigenetic Repression of DNA Mismatch Repair by Inflammation and Hypoxia in Inflammatory Bowel Disease–Associated Colorectal Cancer
2009 StandoutNobel
The Pervasive Presence of Fluctuating Oxygenation in Tumors
2008
Autonomic Nerve Development Contributes to Prostate Cancer Progression
2013 StandoutScience
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
[1] Measurement of absolute oxygen levels in cells and tissues using oxygen sensors and 2-nitroimidazole EF5
2002
Nasopharyngeal carcinoma
2005 Standout
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial
2002
Targeting hypoxia in cancer therapy
2011 Standout
Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx
1990
Repopulation in radiation oncology: perspectives of clinical research
2003
The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials
2001 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial
1997
Chemical Radiosensitizers for Use in Radiotherapy
2007
Anaplastic Lymphoma Kinase Gene Rearrangements in Non-small Cell Lung Cancer are Associated with Prolonged Progression-Free Survival on Pemetrexed
2011
Altered fractionation and combined radio-chemotherapy approaches
2003
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
2014 Standout
Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial
1999
A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer
1997
A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer
1997
Lung Cancer
2008 Standout
Head and neck cancer
2008 Standout
Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
2008
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Amifostine in clinical oncology: current use and future applications
2002
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Accelerated Fractionation in the Radiation Treatment of Head and Neck Cancer—A Critical Comparison of Different Strategies
1988
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
Predicting outcomes in radiation oncology—multifactorial decision support systems
2012
Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer
1998 Standout
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Toxicity in head and neck cancer: a review of trends and issues
2000
Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial
1997
Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis
2000
Radiosensitization by a new potent nucleoside analog: 1-(1′,3′,4′-trihydroxy-2′-butoxy)methyl-2-nitroimidazole(RP-343)
1993 StandoutNobel
Exploiting tumour hypoxia in cancer treatment
2004 Standout
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
The rationale for continuous, hyperfractionated, accelerated radiotherapy (chart)
1990
A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
2000 Standout
Towards evidence based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapy
1998
High-tech in radiation oncology: should there be a ceiling?
2004
Comparison of Conventional and Split-Course Radiotherapy as Primary Treatment in Carcinoma of the Larynx
1988
Nasopharyngeal carcinoma
2015 Standout
The pathobiology of mucositis
2004 Standout
Partial rescue of defects in Cited2-deficient embryos by HIF-1α heterozygosity
2006 StandoutNobel
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.
1998
The Hypoxic Tumour Microenvironment, Patient Selection and Hypoxia-modifying Treatments
2007
Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer
1995
Targeting gene expression to hypoxic tumor cells
1997 StandoutNobel
Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer
2000
Head and Neck Cancer
1993 Standout
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
2011 StandoutNobel
Concomitant radiochemotherapy or accelerated radiotherapy: Analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC)
2004
Mediastinal Lymph Node Staging With FDG-PET Scan in Patients With Potentially Operable Non-small Cell Lung Cancer
1997
Negative Regulation of Hypoxic Responses via Induced Reptin Methylation
2010 StandoutNobel
New Radiation Therapy Techniques for the Treatment of Head and Neck Cancer
2005
HIF-1α, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors
2002 StandoutNobel
Synthesis of 11C, 18F, 15O, and 13N Radiolabels for Positron Emission Tomography
2008
A Phase III Randomized Trial of Combined Chemoradiotherapy Versus Radiotherapy Alone in Locally Advanced Non–Small-Cell Lung Cancer
2002
PET-CT–Based Auto-Contouring in Non–Small-Cell Lung Cancer Correlates With Pathology and Reduces Interobserver Variability in the Delineation of the Primary Tumor and Involved Nodal Volumes
2007
Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications
2000
Staging of non-small cell lung cancer: consensus, controversies and challenges
2001
A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer: An interim toxicity analysis of the first 100 patients
1995
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
2014 Standout
Modes of resistance to anti-angiogenic therapy
2008 Standout
Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck – A systematic review and meta-analysis
2011
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Head and Neck Cancer
2001 Standout
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Perineural invasion in cancer
2009 Standout
Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
2005 Standout
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
3d Transition Metals for C–H Activation
2018 Standout
Chemical Design and Synthesis of Functionalized Probes for Imaging and Treating Tumor Hypoxia
2017
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
2008 StandoutNobel
Patient-to-Patient Variability in the Expression of Radiation-Induced Normal Tissue Injury.
1994
A clinical phase I toxicity study of Ro 03–8799: plasma, urine, tumour and normal brain pharmacokinetics
1986
Liposomal Doxorubicin and Conventionally Fractionated Radiotherapy in the Treatment of Locally Advanced Non–Small-Cell Lung Cancer and Head and Neck Cancer
1999
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
2002 Standout
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
2001 Standout
Hyperfractionated Accelerated Chemoradiation With Concurrent Fluorouracil-Mitomycin Is More Effective Than Dose-Escalated Hyperfractionated Accelerated Radiation Therapy Alone in Locally Advanced Head and Neck Cancer: Final Results of the Radiotherapy Cooperative Clinical Trials Group of the German Cancer Society 95-06 Prospective Randomized Trial
2005
The clinical testing of Ro 03-8799—Pharmacokinetics, toxicology, tissue and tumor concentrations
1984
Synthese von 11C‐, 18F‐, 15O‐ und 13N‐Radiotracern für die Positronenemissionstomographie
2008
Radiation sensitization and chemopotentiation: Rsu 1069, a compound more efficient than misonidazole in vitro and in vivo
1984
Spontaneous Transformation of Cultured Mouse Bone Marrow–Derived Stromal Cells
2006 StandoutNobel
Microenvironment-induced cancer metastasis
2000
The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.
1998
18F-Labeling of Arenes and Heteroarenes for Applications in Positron Emission Tomography
2016
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Carboplatin/Paclitaxel or Carboplatin/Vinorelbine Followed by Accelerated Hyperfractionated Conformal Radiation Therapy: Report of a Prospective Phase I Dose Escalation Trial From the Carolina Conformal Therapy Consortium
2004
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Direct Demonstration of Instabilities in Oxygen Concentrations within the Extravascular Compartment of an Experimental Tumor
2006
Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy
2002
Brief Physician-Initiated Quit-Smoking Strategies for Clinical Oncology Settings: A Trial Coordinated by the Eastern Cooperative Oncology Group
2003
Late Stage Benzylic C–H Fluorination with [18F]Fluoride for PET Imaging
2014
Phase II trial of hyperfractionated accelerated radiation therapy for nonresectable non-small-cell lung cancer: results of Eastern Cooperative Oncology Group 4593.
1998
Patient-to-patient variability in the expression of radiation-induced normal tissue injury
1994
Comparisons among Pimonidazole Binding, Oxygen Electrode Measurements, and Radiation Response in C3H Mouse Tumors
1999
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma
1998
A Multitargeted, Metronomic, and Maximum-Tolerated Dose “Chemo-Switch” Regimen is Antiangiogenic, Producing Objective Responses and Survival Benefit in a Mouse Model of Cancer
2004
Works of M.I. Saunders being referenced
Phase II-I-II Study of Two Different Doses and Schedules of Pralatrexate, a High-Affinity Substrate for the Reduced Folate Carrier, in Patients With Relapsed or Refractory Lymphoma Reveals Marked Activity in T-Cell Malignancies
2009
Blockade of PDGF receptor beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and increased tumor vascularised volume
2005
Microregional fluctuations in perfusion within human tumours detected using laser Doppler flowmetry
1996
The problem of cigarette smoking in radiotherapy for cancer in the head and neck
1992
CHART Revisited: A Conservative Approach for Advanced Head and Neck Cancer
2007
Dose-escalation with CHARTWEL (Continuous Hyperfractionated Accelerated Radiotherapy Week-End Less) Combined with Neo-adjuvant Chemotherapy in the Treatment of Locally Advanced Non-small Cell Lung Cancer
2002
A Pilot Study of Postoperative CHART and CHARTWEL in Head and Neck Cancer
2000
Radiotherapy for Inoperable Lung Cancer
2001
From CHART to CHARTWEL in Non-small Cell Lung Cancer: Clinical Radiobiological Modelling of the Expected Change in Outcome
2002
Carbogen breathing increases prostate cancer oxygenation: a translational MRI study in murine xenografts and humans
2009
Radiotherapy Employing Three Fractions on Each of Twelve Consecutive Days
1988
Positron Emission Tomography in Oncology: A Review
2007
Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced non-small-cell lung cancer: A competing risks analysis
2001
Precision in reporting the dose given in a course of radiotherapy
1993
The long term outcome after radical radiotherapy for advanced head and neck cancer
1993
Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee
1996
Is control of the primary tumour worthwhile in non-oat cell carcinoma of the bronchus
1991
Radiotherapy employing three fractions in each day over a continuous period of 12 days
1986
Pretreatment minimal staging for non-small cell lung cancers: a consensus report
1991
The pharmacokinetics of a new radiosensitiser, Ro 03-8799 in humans
1984
Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide.
1996
Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell lung cancer
1993
The radiosensitizer Ro 03-8799 and the concentrations which may be achieved in human tumours: a preliminary study
1982